help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1719
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hampe, C. S.
Right arrow Articles by Balasubramanyam, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hampe, C. S.
Right arrow Articles by Balasubramanyam, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Diabetes Type 1
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Autoimmunity
Right arrow Diabetes and Insulin
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 2 462-467
Copyright © 2007 by The Endocrine Society

Association of Amino-Terminal-Specific Antiglutamate Decarboxylase (GAD65) Autoantibodies with ß-Cell Functional Reserve and a Milder Clinical Phenotype in Patients with GAD65 Antibodies and Ketosis-Prone Diabetes Mellitus

Christiane S. Hampe, Ramaswami Nalini, Mario R. Maldonado, Tyler R. Hall, Gilberto Garza, Dinakar Iyer and Ashok Balasubramanyam

Robert H. Williams Laboratory (C.S.H., T.R.H.), Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98195; Translational Metabolism Unit (R.N., M.R.M., D.I., A.B.), Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, and Endocrine Service (R.N., G.G., A.B.), Ben Taub General Hospital, Houston, Texas 77030; and Bristol-Myers-Squibb, Co. (M.R.M.), Princeton, New Jersey 08540

Address all correspondence and requests for reprints to: Christiane S. Hampe, Ph.D., Department of Medicine, University of Washington, Seattle, Washington 98195. E-mail: champe{at}u.washington.edu.

Context: We previously characterized patients presenting with diabetic ketoacidosis prospectively into four subgroups of ketosis-prone diabetes mellitus (KPDM), based on the presence or absence of ß-cell autoimmunity (A+ or A–) and ß-cell functional reserve (B+ or B–). The A+B– KPDM subgroup comprises patients with classic, autoimmune type 1 diabetes, whereas the A+B+ KPDM subgroup has only partial ß-cell loss and a distinct clinical phenotype.

Objective: We hypothesized that epitope specificity of autoantibodies directed against the 65-kDa isoform of glutamate decarboxylase (GAD65) reflects differences in ß-cell destruction.

Design: Sera of sequential GAD65Ab-positive KPDM patients admitted for diabetic ketoacidosis (n = 36) were analyzed for their epitope recognition using five GAD65-specific recombinant Fab and their ability to inhibit GAD65 enzymatic activity. All patients were followed longitudinally to assess ß-cell functional reserve and insulin dependence.

Results: Binding to an amino-terminal epitope defined by monoclonal antibody DPD correlated positively with fasting serum C-peptide levels at baseline (P = 0.0008) and after 1 yr (P = 0.007). Binding to the DPD-defined epitope also correlated positively with area under the curve for C-peptide after glucagon stimulation (P = 0.007) and with homeostasis model assessment percent B at 1 yr (P = 0.03). Binding to the DPD-defined epitope was significantly stronger in A+B+ than in A+B– patients (P = 0.001). Sera of 16 patients (44%) significantly inhibited GAD65 enzymatic activity, but this did not correlate with ß-cell function.

Conclusion: DPD-defined epitope specificity is correlated directly with preserved ß-cell functional reserve in GAD65Ab-positive patients and is associated with the milder clinical phenotype of A+B+ KPDM.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
A. Balasubramanyam, R. Nalini, C. S. Hampe, and M. Maldonado
Syndromes of Ketosis-Prone Diabetes Mellitus
Endocr. Rev., May 1, 2008; 29(3): 292 - 302.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Fenalti, C. S. Hampe, Y. Arafat, R. H.P. Law, J. P. Banga, I. R. Mackay, J. C. Whisstock, A. M. Buckle, and M. J. Rowley
COOH-Terminal Clustering of Autoantibody and T-Cell Determinants on the Structure of GAD65 Provide Insights Into the Molecular Basis of Autoreactivity
Diabetes, May 1, 2008; 57(5): 1293 - 1301.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society